New Beiyang: the subsidiary won the bid for the procurement project of China Post super teller machine

Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?

Since the biotechnology pharmaceutical scene has become a red ocean, attracting new entrants and capital, TCM players are encountering some harsh new realities.

Unpacking China | Key Chinese Firms to Watch This Week （12/04/2026-17/04/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Chinese EV leader BYD (比亚迪) South Africa avoids price war, focusing on long-term brand value via differentiation

On April 15, Steve Chang, Managing Director of BYD South Africa, stated at the launch of the ATTO 8 in Johannesburg that the company will firmly avoid frequent price cuts despite intensifying competition. While many new Chinese NEV entrants are relying on deep launch discounts to gain market share, BYD is pursuing a more patient brand-building path centered on "price parity."

Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)

Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.

Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)

Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.